Draeger clinical article
Why I Stopped Treating Anesthesia Workstations Like the Only Decision on My Plate
2026-05-31 · Jane Smith
-
If you manage purchasing for a hospital or large clinic, here is the short version: stop comparing anesthesia workstations spec-by-spec in a vacuum.
-
How a single failure changed my entire approach
-
The specific change: bump test stations and fetal monitoring
-
What this means for your purchasing process
-
When this approach doesn't apply
If you manage purchasing for a hospital or large clinic, here is the short version: stop comparing anesthesia workstations spec-by-spec in a vacuum.
The real cost—and the real risk—lives in how that device talks to your existing gas detection, the reliability of your air monitors, and whether the system can integrate with your biosafety cabinet protocols. I learned this the hard way in 2023, and it changed how I spend roughly $1.2M annually across my vendors.
How a single failure changed my entire approach
I took over our medical equipment purchasing in 2020. Everything I'd read about buying anesthesia machines said to focus on the ventilator specs—tidal volume accuracy, PEEP stability, that kind of thing. Which, yes, matters. But in October 2023, we had a near-miss event that redefined my priorities.
Our lead anesthesiologist set up a new Dräger workstation for a complex case. Everything looked good on the device screen. But the room—our ceiling-mounted gas detector—had been calibrated 14 months prior and was starting to drift. It didn't alarm when there was a minor agent leak. (Should mention: the machine itself has redundant alarms, but the room-level monitoring lagged.) No one got hurt, but post-incident review revealed the problem.
I didn't fully understand the value of an integrated safety ecosystem until that incident. Since then, I've made it a rule that any major anesthesia purchase must include a verification protocol that covers the room's air monitor, a compatible bump test station, and a review of how the device interacts with our biosafety cabinet exhaust system.
Hit 'approve' on that change and immediately thought 'should I have been doing this all along?' Didn't relax until our next JCAHO audit when the surveyor actually complimented our integrated verification process (surprise, surprise).
The specific change: bump test stations and fetal monitoring
Let me be specific. The conventional wisdom is to buy the anesthesia workstation first and figure out ancillary equipment later. I now do the opposite. Here's a concrete example from our OR expansion in early 2024:
We were selecting a Dräger Fabius (or similar) workstation. Instead of starting with the ventilator specs, I started with the Dräger bump test station for our gas detectors. Why? Because if your gas detector isn't tested daily with a known concentration, you're flying blind on room safety. The bump test station for Dräger sensors (like the X-am 5000) costs about $1,200 and takes 2 minutes per unit. Skipping it to save $7,000 a year? Not worth the risk after October 2023.
(I should add that we also have a biosafety cabinet in that OR for specific procedures. The cabinet's exhaust must be negative pressure relative to the room. A standard anesthesia workstation isn't designed for that. We ended up choosing a model with a dedicated scavenging interface—something I would have missed if I'd only focused on the ventilator specs.)
Oh, and on fetal monitors: a nurse manager asked me, “How does a fetal monitor work with our existing network?” Most vendors will tell you their monitor outputs standard data. That's true. But we had a compatibility issue with our central display station. The fix was a $0 software patch, but the discovery cost us 6 weeks of delay because I hadn't verified integration upfront. Now I ask every vendor for a written statement of compatibility with our HIS and central monitoring software before I even schedule a demo.
What this means for your purchasing process
Based on managing 60-80 medical device orders annually across 8 vendors, here's the practical workflow I've landed on:
- Start with the weak link. For us, it was gas detection and bump testing. For you, it might be biosafety cabinet exhaust integration or fetal monitor network compatibility. Identify the single point of failure in your existing setup first.
- Demand a system-level verification package. Don't just ask for the anesthesia workstation specs. Ask for a written protocol on how the device will be tested alongside your existing Dräger air monitors and bump test station. If the vendor can't provide one, that's a red flag.
- Price the ancillaries before the main device. The $1,200 for a bump test station is nothing compared to the cost of a misstep. But if you buy the workstation first and then realize you need new detectors or a different exhaust interface—suddenly your budget is gone.
Per the Dräger gas detection system manual (I keep a printed copy on my desk), bump testing should be performed before each use or daily. We do it before first-case start. The sensors have a 2-year lifespan and need calibration every 6 months. A $2,400/year investment in bump testing and calibration for our OR suite is cheap insurance compared to the liability of a missed leak.
When this approach doesn't apply
I recommend this integrated approach for hospitals and large surgical centers where equipment is used by multiple teams and the room configuration is complex. But if you're a single-specialty clinic with one anesthesia machine and a dedicated tech who handles all maintenance? You probably don't need a formal bump test station or a system-level verification protocol. You can get away with manual daily checks and a good relationship with your service rep.
Also, this assumes you have a Dräger (or similar) monitoring ecosystem. If you're buying a GE or Philips workstation and pairing it with a different brand of gas detectors, the integration needs are different. The principle—test system integration first—still holds, but the specific requirements will change.
Since implementing this process, our number of anesthesia-related safety incidents dropped from 2 (with 1 near-miss) in 2023 to 0 in 2024. The feedback from our clinicians? Overwhelmingly positive. They feel safer, and that's worth more than any single spec sheet figure.